Filovirus proteins for antiviral drug discovery: A structure/function analysis of surface glycoproteins and virus entry
- 1 November 2016
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 135, 1-14
Abstract
No abstract availableKeywords
Funding Information
- DGA-MRIS
- Aix-Marseille Université scholarship (ANR-ST14-ASTR-0026)
This publication has 159 references indexed in Scilit:
- A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat AgentsPLOS ONE, 2013
- Ebola virus entry requires the host‐programmed recognition of an intracellular receptorThe EMBO Journal, 2012
- Bidentate and tridentate metal-ion coordination states within ternary complexes of RB69 DNA polymeraseProtein Science, 2012
- Differential requirements for clathrin endocytic pathway components in cellular entry by Ebola and Marburg glycoprotein pseudovirionsVirology, 2011
- Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoproteinVirology, 2011
- Ebola haemorrhagic feverThe Lancet, 2011
- C-type lectins do not act as functional receptors for filovirus entry into cellsBiochemical and Biophysical Research Communications, 2010
- Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviationsArchives of Virology, 2010
- Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoproteinVirology, 2009
- Structure of the Ebola virus glycoprotein bound to an antibody from a human survivorNature, 2008